JPMorgan Funds - Global Healthcare Fund C (dist) - USDRegister to Unlock Ratings |
Performance History | 30/04/2024 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | 20.6 | 12.9 | 2.9 | -2.4 | 5.8 | |
+/-Cat | 3.1 | 3.5 | 7.5 | 0.7 | 3.8 | |
+/-B’mrk | - | -5.3 | -2.9 | 0.2 | 1.0 | |
Category: Sector Equity Healthcare | ||||||
Category Benchmark: Morningstar Gbl Health TME ... |
Key Stats | ||
NAV 30/04/2024 | USD 268.41 | |
Day Change | 0.71% | |
Morningstar Category™ | Sector Equity Healthcare | |
ISIN | LU0945067352 | |
Fund Size (Mil) 30/04/2024 | USD 4184.73 | |
Share Class Size (Mil) 30/04/2024 | USD 8.94 | |
Max Initial Charge | - | |
Ongoing Charge 06/12/2023 | 1.00% |
Investment Objective: JPMorgan Funds - Global Healthcare Fund C (dist) - USD |
To achieve a return by investing primarily in pharmaceutical, biotechnology, healthcare services, medical technology and life sciences companies ("Healthcare Companies"), globally. |
Returns | ||||||||||||||||
|
Management | ||
Manager Name Start Date | ||
Holly Fleiss 09/06/2022 | ||
Dominic Valder 05/10/2022 | ||
Click here to see others | ||
Inception Date 08/07/2013 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
MSCI World/Health Care NR USD | Morningstar Gbl Health TME NR USD |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for JPMorgan Funds - Global Healthcare Fund C (dist) - USD | 31/03/2024 |
|
|
Top 5 Holdings | Sector | % |
Eli Lilly and Co | Healthcare | 9.01 |
UnitedHealth Group Inc | Healthcare | 7.66 |
Novo Nordisk A/S Class B | Healthcare | 5.96 |
AbbVie Inc | Healthcare | 5.17 |
Regeneron Pharmaceuticals Inc | Healthcare | 4.54 |
Increase Decrease New since last portfolio | ||
JPMorgan Funds - Global Healthcare Fund C (dist) - USD |